Michael G Grey is of Mirati Therapeutics, Inc.. Currently has a direct ownership of 5,731 shares of MRTX, which is worth approximately $0. The most recent transaction as insider was on Jan 15, 2021, when has been sold 1,475 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.73K
0% 3M change
0% 12M change
Total Value Held $0

MICHAEL G GREY Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 15 2021
BUY
Grant, award, or other acquisition
-
1,475 Added 20.47%
5,731 Common Stock
Dec 14 2020
SELL
Open market or private sale
$2,674,969 $245.41 p/Share
10,900 Reduced 71.92%
4,256 Common Stock
Dec 14 2020
BUY
Exercise of conversion of derivative security
$183,556 $16.84 p/Share
10,900 Added 41.83%
15,156 Common Stock

Also insider at

HZNP
Horizon Therapeutics Public Ltd Co Healthcare
BMRN
BIOMARIN PHARMACEUTICAL INC Healthcare
RPHM
Reneo Pharmaceuticals, Inc. Healthcare
SPRB
SPRUCE BIOSCIENCES, INC. Healthcare
MIRM
Mirum Pharmaceuticals, Inc. Healthcare
MGG

Michael G Grey

Dublin, L2

Track Institutional and Insider Activities on MRTX

Follow Mirati Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRTX shares.

Notify only if

Insider Trading

Get notified when an Mirati Therapeutics, Inc. insider buys or sells MRTX shares.

Notify only if

News

Receive news related to Mirati Therapeutics, Inc.

Track Activities on MRTX